Trending/HELIOS study
Targeted Drug with Chemotherapy Combo Offers Longer Life to Patients with B-cell Cancers
CHICAGO — Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small…
No information found.
Special Topics
Sign up
Mayo Clinic Connect
An online patient support community